← back to search

Alessandro Fichera

University of Huddersfield · GB
🔎 Find collaborators in Oncology · Genetics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Oncology · Genetics
Research interest
Research interests include Colorectal Cancer Surgical Treatments, Inflammatory Bowel Disease, Diverticular Disease and Complications, and Gastric Cancer Management and Outcomes.
h-index
46
citations
8,500
works
340
NIH funding
primary concept
email

Recent publications

Lasting Lower Rhine–Meuse forager ancestry shaped Bell Beaker expansion
Nature 2026cited by 3position: middledoi
A deep-learning model to predict the completeness of cytoreductive surgery in colorectal cancer with peritoneal metastasis☆
European Journal of Surgical Oncology 2025cited by 6position: middledoi
Long-term Outcomes Following Colectomy and Liver Transplantation for Inflammatory Bowel Disease With Primary Sclerosing Cholangitis
Annals of Surgery 2024cited by 9position: middledoi
Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset
Cancers 2021cited by 28position: middledoi
Upregulation of polycistronic microRNA-143 and microRNA-145 in colonocytes suppresses colitis and inflammation-associated colon cancer
Epigenetics 2020cited by 18position: middledoi
Challenges in IBD Research: Preclinical Human IBD Mechanisms
Inflammatory Bowel Diseases 2019cited by 88position: middledoi
Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer
Annals of Surgery 2018cited by 402position: middledoi
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial
Diseases of the Colon & Rectum 2018cited by 164position: middledoi
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2017cited by 1,370position: middledoi
miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling
Inflammatory Bowel Diseases 2017cited by 29position: middledoi
Preoperative Immunonutrition and Elective Colorectal Resection Outcomes
Diseases of the Colon & Rectum 2016cited by 59position: middledoi
ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer
Clinical Cancer Research 2016cited by 43position: middledoi
Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes
JAMA 2015cited by 1,089position: middledoi
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
The Lancet Oncology 2015cited by 693position: middledoi
Guidelines for the Multidisciplinary Management of Crohnʼs Perianal Fistulas
Inflammatory Bowel Diseases 2015cited by 82position: middledoi
Preoperative Infliximab Therapy Does Not Increase Morbidity and Mortality After Laparoscopic Resection for Inflammatory Bowel Disease
Diseases of the Colon & Rectum 2013cited by 68position: lastdoi
Does Morbid Obesity Change Outcomes after Laparoscopic Surgery for Inflammatory Bowel Disease? Review of 626 Consecutive Cases
Journal of the American College of Surgeons 2013cited by 59position: lastdoi
Gene Signature Distinguishes Patients with Chronic Ulcerative Colitis Harboring Remote Neoplastic Lesions
Inflammatory Bowel Diseases 2013cited by 54position: middledoi
Rescue Therapy with Cyclosporine or Infliximab is not Associated with an Increased Risk for Postoperative Complications in Patients Hospitalized for Severe Steroid-refractory Ulcerative Colitis
Inflammatory Bowel Diseases 2013cited by 52position: middledoi
Modern Rectal Cancer Multidisciplinary Treatment: The Role of Radiation and Surgery
Annals of Surgical Oncology 2013cited by 30position: lastdoi
Paradigm-Shifting New Evidence for Treatment of Rectal Cancer
Journal of Gastrointestinal Surgery 2013cited by 15position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Joel Pekow · Perrigo (United States)5 papers (2013–2020)Roger D. Hurst · University of Chicago4 papers (2013–2017)Marco E. Allaix · Torino e-district4 papers (2013–2013)John Hart · United Continental (United States)4 papers (2013–2020)Marc Bissonnette · University of Illinois Chicago4 papers (2013–2020)Marco Zoccali · NewYork–Presbyterian Hospital3 papers (2013–2015)Loren Joseph · Beth Israel Deaconess Medical Center3 papers (2013–2020)Urszula Dougherty · Argonne National Laboratory3 papers (2013–2020)Konstantin Umanskiy · University of Chicago3 papers (2013–2017)Daniel J. Sargent · National Institute of Agricultural Botany2 papers (2015–2018)Michael J. Stamos · University of California System2 papers (2015–2018)Sherry M. Wren · VA Palo Alto Health Care System2 papers (2015–2018) · 2 papers (2015–2018) · 2 papers (2015–2018)David W. Larson · Mayo Clinic2 papers (2015–2018)Reba Mustafi · University of Chicago2 papers (2016–2020)David T. Rubin · University of California System2 papers (2013–2017)George J. Chang · The University of Texas MD Anderson Cancer Center2 papers (2015–2018)Steven D. Wexner · MedStar Georgetown University Hospital2 papers (2015–2018)Peter W. Marcello · Tufts University2 papers (2015–2018)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Genetics →